BioSpace News Archive

Drug Development

Catabasis Pharma Will Present CAT-1004, A Potential Disease-Modifying Agent In Development For The Treatment Of Duchenne Muscular Dystrophy, At The XIV International Conference On Duchenne And Becker Muscular Dystrophy

February 10, 2016
·
1 min read
Drug Development

Sosei Subsidiary Heptares Announces Positive Results From Phase 1b Clinical Trial With HTL9936, A First-In-Class Selective Muscarinic M1Receptor Agonist For Improving Cognition In Dementia And Schizophrenia

February 10, 2016
·
8 min read
Drug Development

Aimmune Announces Presentation At The 2016 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

February 10, 2016
·
1 min read
Immunovia And Lund University Start Clinical Validation Studies Of Systemic Lupus Erythematosus (SLE) Biomarker Signatures

February 10, 2016
·
5 min read
Genetown

BioPharm Clinical And SiteSurvey To Unveil New Features At SCOPE

February 10, 2016
·
1 min read
Policy

Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications

February 10, 2016
·
5 min read
BioCapital

Japanese Patent Office Issues Decision To Grant Patent For USMI’s Canady Hybrid Plasma Technology

February 10, 2016
·
2 min read
Pharm Country

Eagle Pharma To Present At RBC Capital Markets 2016 Global Healthcare Conference

February 10, 2016
·
1 min read
Allergan To Present At The RBC Capital Markets Healthcare Conference

February 10, 2016
·
3 min read
Policy

FDA’s Arthritis Advisory Committee Recommends Approval Of Celltrion’s CT-P13, A Proposed Biosimilar Infliximab, For All Indications

February 10, 2016
·
3 min read